This summary highlights significant corporate announcements and trading activities from the Hong Kong stock market.

Key Corporate Developments

HQVT (01392) has initiated its public offering period, running from June 11th to June 16th, with plans to issue approximately 85,162,500 H shares globally.

CHINASOFT INT'L (00354) has officially launched the allmeta Ontology v1.0, a platform designed to provide a high-performance workspace for Full Digital Engineering (FDE).

SEYOND (02665) reported total LiDAR product shipments of around 365,000 units for the first five months of the year, representing a year-on-year increase of approximately 349%, which has already surpassed the total shipments for the entire year of 2025.

Ease Health (02661) has entered into a strategic cooperation memorandum with Basel Medical to facilitate mutual development in technology export and iteration.

Huayi Jin Kong (08123) is considering advancing a debt capitalisation plan, which may lead to a change in control and trigger a mandatory general offer.

Quasar International (00381) intends to collaborate with Yalu Cloud in areas including corporate mergers and restructuring, as well as deep capital cooperation.

Longpan Technology (02465) announced that its subsidiary, Lithium Source (Asia Pacific), plans to invest in the construction of the third-phase Lithium Source Indonesia (Batam) project through its Indonesian entity.

Shi Teng Holdings (02562) has partnered with Meiya Entertainment (00391) to jointly launch the AI-driven brand "MASYN".

Alphamab Oncology (09966) announced that the Phase III clinical study of its drug candidate, Envafolimab (KN026), for the first-line treatment of HER2-positive advanced breast cancer, has met its primary endpoint.

CSPC Pharmaceutical Group (01093) reported that the Phase III study of Envafolimab (KN026) combined with Albumin-bound Docetaxel for Injection (HB1801) for the first-line treatment of HER2-positive advanced breast cancer has also met its primary endpoint.

Kintor Pharmaceutical (09939) announced favorable interim data from the long-term human safety trial of KT-939 and has commenced new drug registration applications for the raw material.

Baoji Pharma (02659) has received approval from the U.S. FDA for the Investigational New Drug (IND) application of its subcutaneous infusion of ceftriaxone sodium, BJ007 injection.

Hansoh Pharma (03692) disclosed that the Marketing Authorisation Application (MAA) for its HS-10568 injection has been accepted for review by China's National Medical Products Administration (NMPA).

Tianqi Lithium (09696) reported a localized fire incident at the third-phase chemical-grade lithium concentrate plant of its subsidiary, Talison.

China Isotope & Radiation Corporation (01763) announced the successful approval of the radiation safety license for the Phase II of its Radiological Source R&D and Production Base, marking the full completion and operation of Asia's largest facility of its kind.

Share Buybacks and Stake Changes

TENCENT (00700) repurchased 1.081 million shares on June 10th, expending approximately HK$501 million.

WuXi AppTec (02359) bought back 2.029 million shares on June 10th, with a total outlay of around HK$243 million.

Li Auto Inc. (02015) repurchased 2.2546 million shares on June 10th, spending about HK$123 million.

S.F. Holding Co., Ltd. (06936) repurchased 2.8734 million A-shares on June 10th, utilizing approximately RMB 99.9936 million.

XIAOMI-W (01810) repurchased 3.7 million shares on June 10th, with an expenditure of about HK$97.3962 million.

GCL Technology (03800) repurchased approximately 109 million shares on June 10th, costing around HK$81.2989 million.

Tigermed (03347) bought back 1.5507 million shares on June 10th, spending roughly RMB 60.0656 million.

MINISO Group Holding Ltd. (09896) repurchased 1.9294 million shares on June 10th, expending about HK$49.9823 million.

Etern Healthcare (06998) announced that its Board Chairman, Ni Xin, intends to increase his stake in the company.

XD Inc. (02400) plans to repurchase shares with a maximum value of HK$400 million.

Feisu Innovation (03355) intends to repurchase up to 5% of the company's H shares.

GCL Technology (03800) also disclosed that its directors and core management personnel plan to increase their holdings in the company.

China Communications Construction Company Limited (01800) announced the completion of its controlling shareholder's share increase plan, with a cumulative purchase of 54.602 million H shares.

China Hongqiao Group Limited (01378) reported that its controlling shareholder has increased its stake by a total of 20.5 million shares.

Operational and Financial Performance

China Resources Power Holdings Company Limited (00836) reported that its affiliated power plants achieved cumulative electricity sales of approximately 101 million MWh in the first five months, a 14.4% year-on-year increase.

Luk Fook Holdings (International) Limited (00590) issued a positive profit alert, expecting annual profit to rise by approximately 80% to 90%.

Zhiyun Technology Construction (09900) issued a profit warning, anticipating annual attributable profit to shareholders to decrease to not less than HK$6.5 million.

Seazen Group Limited (01030) reported cumulative contracted sales of approximately RMB 5.400 billion for the first five months, a decrease of 38.89% year-on-year.

Yuzhou Group Holdings Company Limited (01628) achieved cumulative sales of RMB 2.301 billion in the first five months.